Device-Assisted ADL Practice for Stroke Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a device can aid in recovering arm movement after a moderate to severe stroke. Participants will practice tasks like reaching and grasping using the ReIn-Hand device and potentially a robot-assisted rehabilitation device to support their shoulder. Researchers aim to improve current treatments and help many stroke survivors regain more use of their affected arm. This trial may suit individuals with one-sided arm weakness after a stroke who can lift their arm and have some hand movement with assistance. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance recovery options for stroke survivors.
Do I need to stop my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you have had botulinum toxin or similar injections in the last 6 months, you may not be eligible.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have had certain injections like botulinum toxin in the last 6 months, you may not be eligible to participate.
What prior data suggests that these devices are safe for stroke recovery?
Research shows that treatments using devices like ReIn-Hand and robotic therapy are being explored to help stroke survivors regain use of their arms and hands. These devices are generally easy to use and aim to improve everyday actions like reaching and grasping.
Studies have found that ReIn-Hand helps by opening the hand, making it easier for people to perform tasks. No specific evidence of serious side effects has been found, which reassures those considering it.
Regarding robotic therapy, research suggests it can enhance arm movement and improve motor skills. Some studies have shown that this therapy is safe and can even boost brain function related to movement.
Overall, both treatments appear safe and promising for recovery after a stroke. However, it is important to consult healthcare providers to determine if they are suitable for individual needs.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for stroke recovery because they incorporate innovative device-assisted techniques to enhance everyday activities. ReIn-Hand helps patients with limited hand function by enabling them to perform tasks like reaching and grasping more effectively. The combination of ReIn-Hand with a robotic system not only aids hand movements but also reduces shoulder strain, offering a more holistic approach to rehabilitation. These treatments stand out because they aim to make daily activities easier for stroke survivors, potentially speeding up recovery and improving quality of life compared to traditional therapies like physical therapy alone.
What evidence suggests that this device-assisted practice is effective for stroke recovery?
Research has shown that the ReIn-Hand device, a treatment in this trial, can help stroke survivors improve hand and arm movement. This device aids in everyday tasks like reaching and gripping, which many stroke survivors find challenging. Studies indicate that practicing these tasks with the device can enhance recovery of movement skills in the affected arm.
In another part of this trial, participants will use both the ReIn-Hand and a robot. Research has found that robot-assisted therapy can boost brain changes (neuroplasticity) and improve movement abilities. Using both the device and robot together might offer even greater benefits for stroke recovery. The combination provides more intensive training, often needed for better results after a stroke.12356Who Is on the Research Team?
Jun Yao, PhD
Principal Investigator
Northwestern University
Are You a Good Fit for This Trial?
This trial is for individuals aged 21-80 who have had a moderate to severe stroke, resulting in significant arm weakness but with some ability to move. They must be able to sit for an hour, have a certain level of cognitive function (MoCA score >=23), and not be receiving other physical rehabilitation. Exclusions include recent seizures, severe sensory impairment in the arm, prior injections affecting muscle control, other neurological disorders or serious medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline clinical assessments and data collection including MRI and EEG
Treatment
Participants engage in 24 sessions of device-assisted practice of activities of daily living over 8 weeks
Post-Intervention Assessment
Participants undergo post-intervention assessments including clinical evaluations and data collection
Follow-up
Participants are monitored for sensory and motor function 3 months after intervention
What Are the Treatments Tested in This Trial?
Interventions
- ReIn-Hand
- Robot
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator